Dr. Oz Opposes Budd Hemp Amendment in Senate

Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz has voiced opposition to a proposed amendment that could lead to a federal ban on most hemp-derived products. In a letter to senators, Oz expressed "grave concerns" about the amendment, which was introduced by Sen. Ted Budd (R-N.C.). The amendment, set to take effect in November, would effectively prohibit the sale of a wide range of hemp-derived products, including CBD oil and other related items.

According to reports, Dr. Oz's concerns center around the potential impact of the ban on public health and the economy. Hemp-derived products have gained popularity in recent years for their perceived health benefits, and a ban could leave many consumers without access to these products. Furthermore, the ban could also have a significant economic impact on businesses that rely on the sale of hemp-derived products. Dr. Oz's letter is likely to influence the debate around the amendment, as the CMS administrator's views carry significant weight in the healthcare community.

The outcome of the amendment remains uncertain, with senators still weighing the pros and cons of the proposed ban. As the debate continues, Dr. Oz's concerns are likely to be a key factor in the decision-making process. The fate of hemp-derived products hangs in the balance, and the consequences of a ban could be far-reaching.